{"id":564716,"date":"2021-09-21T09:06:01","date_gmt":"2021-09-21T09:06:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=564716"},"modified":"2021-09-21T09:06:01","modified_gmt":"2021-09-21T09:06:01","slug":"microrna-market-size-is-projected-to-reach-351-billion-by-2028-cagr-201-polaris-market-research","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/microrna-market-size-is-projected-to-reach-351-billion-by-2028-cagr-201-polaris-market-research_564716.html","title":{"rendered":"microRNA Market Size Is Projected To Reach $3.51 Billion By 2028 | CAGR: 20.1%: Polaris Market Research"},"content":{"rendered":"
\n
\"microRNA<\/a><\/div>\n
\n
Polaris Market Research<\/div>\n<\/div>\n<\/div>\n
The new published report by Polaris Market Research The global microRNA market was valued at USD 856.9 million in 2020 and is expected to reach USD 3.51 billion by 2028 to grow at a CAGR of 20.1% during the forecast period.<\/div>\n

The global microRNA market<\/a><\/strong> size is expected to reach USD 3.51 billion by 2028<\/strong> according to a new study by Polaris Market Research. The report “microRNA Market Share, Size, Trends, Industry Analysis Report, By Product (Instruments, Consumables); By Services (Service Type, Specimen); By Application (Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease); By End-Use; By Regions; Segment Forecast, 2021 – 2028”<\/em><\/strong> gives a detailed insight into current market dynamics and provides analysis on future market growth. <\/p>\n

The rising adoption of microRNA as a biomarker is also driving the market. These biomarkers are particularly important in genome-wide population studies, data-driven methods, as they have the ability to demonstrate high robustness and reproducibility, as compared to traditional procedures. Hence, such molecules serve as a promising drug candidate to develop biomarkers. Moreover, growing interest in liquid-based biopsies has further led to its increased importance in biomarker discovery and further development. <\/p>\n

Request A Sample Report At: https:\/\/www.polarismarketresearch.com\/industry-analysis\/microrna-market\/request-for-sample<\/a><\/strong> <\/p>\n

Continuous rise in research activities has also explored the potential of microRNA biomarkers across prognosis, therapeutics, and diagnosis to favor the market expansion in near future. In this direction, in January 2020, research scholars have explored the presence of microRNA in the peripheral blood vessel as a biomarker to diagnose bipolar II disorder using NGS. These microRNAs could serve as a possible non-invasive solution to diagnose any indication of neurodegenerative disorders. <\/p>\n

The cardiovascular segment is projected to witness a lucrative market growth rate over the assessment period. This is primarily due to the introduction of novel biomarkers for early diagnosis of heart-related ailments, and significant investments in the sector. <\/p>\n

List Of Company Profiles<\/strong><\/p>\n